MilliporeSigma

MilliporeSigma - MilliporeSigma is the Life Science business of Merck KGaA, Darmstadt, Germany, a top three player in the global life sciences industry. The $8.1 billion Life Science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. MilliporeSigma employs some 22,000 employees worldwide, including approximately 2500 employees in the New England region. With a life science center in Burlington, MA, a significant site in Jaffrey, NH,and 59 manufacturing sites worldwide, the company has a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Throughout 2020, MilliporeSigma has played a vital role in the response to the COVID-19 global pandemic, providing critical raw materials, technologies, and services to support the development of diagnostics, treatments and vaccines, including for more than 35 testing solutions, nearly 50 different vaccines, and 20 monoclonal antibody, plasma products and antivirals. Interim CEO Christos Ross will accept the award on the company's behalf.